ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT

Mederacke, I.Yurdaydin, C.Bremer, B.Cakaloglu, Y.Erhardt, A.Yalcin, K.Zachou, K.2024-04-242024-04-2420100168-8278https://doi.org/10.1016/S0168-8278(10)60323-6https://hdl.handle.net/11468/1628645th Annual Meeting of the European-Association-for-the-Study-of-the-Liver -- APR 14-18, 2010 -- Vienna, AUSTRIA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENTANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENTConference Object52S135S135WOS:00027701800032210.1016/S0168-8278(10)60323-6Q1